Where it comes from
- Made in
- Cytotoxic T cells and natural killer cells, stored in their granules with perforin and granzymes
- Sent out by
- When the killer cell meets an infected or malignant target
- Acts on
- Bacteria (including tuberculosis), fungi and parasites inside cells
- Tumour cells
- Keratinocytes in drug reactions
What it does
In medicine
- The main executioner in Stevens-Johnson syndrome and toxic epidermal necrolysis: blister fluid is full of it, and blood granulysin is a research marker 1
- Nothing is treated through it; what is studied is whether the measurement can tell those reactions from a harmless drug rash early enough to matter 1
Beyond the body’s own use
- Engineered fragments are tested as antibiotics and as anticancer agents in the laboratory; none is in a trial
- Mice have no granulysin gene, so every question about it has to be asked in human cells or in mice given the human one; that is the main reason it is less developed than perforin or the granzymes 2
Sources
- Chung et al., Granulysin is a key mediator of keratinocyte death in Stevens-Johnson syndrome, Nature Medicine 2008
- Krensky & Clayberger, Biology and clinical relevance of granulysin, Tissue Antigens 2009
- Stenger et al., An antimicrobial activity of cytolytic T cells mediated by granulysin, Science 1998
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.